Cystic Fibrosis
What's New
Last Posted: Dec 21, 2020
- [50 years of the Neonatal Screening Program in Catalonia.]
Marín Soria Jose Luis et al. Revista espanola de salud publica 2020 Dec 94 - [Evaluation and perspective of 20 years of neonatal screening in Galicia. Program results.]
Sánchez Pintos Paula et al. Revista espanola de salud publica 2020 Dec 94 - [Impact of the inclusion of second-tier tests in the newborn screening program of Catalonia and in other international programs.]
Pajares García Sonia et al. Revista espanola de salud publica 2020 Dec 94 - [Response of the Catalonia neonatal screening laboratory to the pandemic of SARS-CoV-2.]
Argudo Ramírez Ana et al. Revista espanola de salud publica 2020 Dec 94 - [Results of the neonatal screening on Western Andalusia after a decade of experience.]
Delgado-Pecellín Carmen et al. Revista espanola de salud publica 2020 Dec 94 - Processing of positive newborn screening results: a qualitative exploration of current practice in England.
Chudleigh Jane et al. BMJ open 2020 Dec 10(12) e044755 - Growth, Body Composition, and Lung Function in Prepubertal Children with Cystic Fibrosis Diagnosed by Newborn Screening.
Owen Elizabeth et al. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2020 Dec - Organoids for personalized treatment of Cystic Fibrosis: Professional perspectives on the ethics and governance of organoid biobanking.
Lensink Michael A et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2020 Dec - Gene therapy for sickle cell disease.
Olowoyeye Abiola et al. The Cochrane database of systematic reviews 2020 Nov 11CD007652 - Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
Barben Jürg et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2020 Nov - Early disease surveillance in young children with cystic fibrosis: A qualitative analysis of parent experiences.
Douglas Tonia A et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2020 Oct - The Changing Face of Cystic Fibrosis and Its Implications for Screening.
Naehrlich Lutz et al. International journal of neonatal screening 2020 Jul 6(3) - Emerging Alternatives to Conventional Clinic Visits in the Era of COVID-19: Adoption of Telehealth at VCU Adult Cystic Fibrosis Center.
Womack Caitlin et al. International journal of general medicine 2020 131175-1186 - Newborn Screening for Cystic Fibrosis: Over the Hump, Still Need to Fine-Tune It.
Castellani Carlo et al. International journal of neonatal screening 2020 Jul 6(3) - Why Do We Screen Newborn Infants for Cystic Fibrosis?
Barben Jürg et al. International journal of neonatal screening 2020 Jul 6(3)
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic discoveries into improved health outcomes related to rare diseases...more
Content Summary
- CDC Information (5)
- NIH Information (8)
- COVID-19 (76)
- CDC Publications (5)
- Human Genome Epidemiologic Studies (678)
- GWAS Studies (4)
- Human Genomics Translation/Implementation Studies (245)
- Genomic Tests Evidence Synthesis (28)
- Genomic Tests Guidelines (13)
- Tier-Classified Guidelines (21)
- Non-Genomics Precision Health (1)
- Pathogen Advanced Molecular Detection (18)
- State Public Health Genomics Programs (25)
- Reviews/Commentaries (216)
- Tools/Methods (3)
- Ethical/Legal and Social Issues (ELSI) (12)
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Dec 28, 2020
- Content source:

